This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Borson-Chazot, F. Articles by Moulin, P. Search for Related Content PubMed PubMed Citation Articles by Borson-Chazot, F. Articles by Moulin, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB FOLIC ACID Medline Plus Health Information Obesity Weight Loss Surgery

Occurrence of Hyperhomocysteinemia 1 Year after Gastroplasty for Severe Obesity

Service d’Endocrinologie (F.B.C, F.L, C.G, L.G, F.B, P.M.), Hôpital de l’Antiquaille, 69005; Service de Médecine Nucléaire (C.H, B.C.), Hôpital Neurologique, 69003; and Clinique Saint-Louis (F.T.), 69009, Lyon, France

Address all correspondence and requests for reprints to: Dr. F. Borson-Chazot, Service d’Endocrinologie, Hôpital de l’Antiquaille, 69005, Lyon, France.

Severe obesity exposes one to an increased risk of cardiovascular mortality. Gastroplasty has been shown to induce substantial weight loss and to improve the atherogenic profile of severely obese subjects. However, vitamin deficiencies after gastroplasty have been reported. Because hyperhomocysteinemia, an independent risk factor for cardiovascular disease, is influenced by nutritional status (and especially by folate intake), we hypothesized that a marginal folate deficiency induced by gastroplasty could promote hyperhomocysteinemia. Thus, plasma homocysteine concentrations were measured by high-performance liquid chromatography in 53 severely obese patients (body mass index = 42 ± 1), before and 1 yr after vertical gastroplasty. Plasma homocysteine concentrations increased, on an average, from 9.9 ± 0.4 to 12.8 ± 0.6 µmol/L (P < 0.0001). This increase in homocysteine levels was observed in two thirds of the subjects, leading to clear-cut hyperhomocysteinemia (>15 µmol/L) in 32%. The changes in homocysteine concentrations were correlated to weight loss (P < 0.001) and to decrease in plasma folate concentrations (P < 0.01). Whereas gastroplasty induced a mean 32-kg weight loss and a striking improvement in conventional risk factors, the occurrence of iatrogenic hyperhomocysteinemia might hamper the benefit of surgery on cardiovascular risk in most of the patients. Our results further support use of a systematic efficient folate supplementation after gastroplasty.

This article has been cited by other articles:

				R. J. Presutti, R. S. Gorman, and J. M. Swain Primary Care Perspective on Bariatric Surgery Mayo Clin. Proc., September 1, 2004; 79(9): 1158 - 1166. [Abstract] [PDF]

				A. L. Bjorke Monsen and P. M. Ueland Homocysteine and methylmalonic acid in diagnosis and risk assessment from infancy to adolescence Am. J. Clinical Nutrition, July 1, 2003; 78(1): 7 - 21. [Abstract] [Full Text] [PDF]